ibuprofen 400mg tablets
de pharmaceuticals - ibuprofen - oral tablet - 400mg
seroquel xr tablet 400mg
luye pharma (singapore) pte. ltd. - quetiapine fumarate 460.50mg eqv quetiapine - tablet, extended release - 400 mg - quetiapine fumarate 460.50mg eqv quetiapine 400 mg
neurontin capsule 400 mg
viatris private limited - gabapentin - capsule - 400 mg - gabapentin 400 mg
viramune xr tablet 400 mg
boehringer ingelheim singapore pte. ltd. - nevirapine anhydrous - tablet, extended release - 400 mg - nevirapine anhydrous 400 mg
gabapentin 400mg capsules
rivopharm (uk) ltd - gabapentin - oral capsule - 400mg
ibuprofen 400mg tablets
mawdsley-brooks & company ltd - ibuprofen - oral tablet - 400mg
celecoxib pfizer
pharmacy retailing (nz) ltd t/a healthcare logistics - celecoxib 400mg; - capsule - 400 mg - active: celecoxib 400mg excipient: croscarmellose sodium gelatin lactose monohydrate magnesium stearate povidone sodium laurilsulfate tekprint green sb-4027 titanium dioxide - symptomatic treatment of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. for the management of acute pain and treatment of primary dysmenorrhoea in adults. the decision to prescribe a selective cox-2 inhibitor should only be made: · if non-pharmacological interventions and simple analgesic therapies have been tried and found to lack analgesic efficacy or to have unacceptable adverse effects in the individual patient, and · after assessment of the individual patient's overall risks. as the cardiovascular risks of the selective cox-2 inhibitors may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. patients on long-term treatment should be reviewed regularly, such as every three months, with regards to efficacy, risk factors and ongoing need for treatment.
kenso agcare squatter 400 ec herbicide
kenso corporation (m) sdn. bhd. - carfentrazone-ethyl; liquid hydrocarbon - emulsifiable concentrate - carfentrazone-ethyl ungrouped active 400.0 g/l; liquid hydrocarbon solvent other 531.0 g/l - herbicide
uptravi selexipag 1400 microgram film-coated tablet blister pack
janssen-cilag pty ltd - selexipag, quantity: 1400 microgram - tablet, film coated - excipient ingredients: mannitol; maize starch; hyprolose; hypromellose; propylene glycol; magnesium stearate; titanium dioxide; carnauba wax; iron oxide yellow - uptravi is indicated for the treatment of:,- idiopathic pulmonary arterial hypertension;,- heritable pulmonary arterial hypertension;,- pulmonary arterial hypertension associated with connective tissue disease;,-pulmonary arterial hypertension associated with congenital heart disease with repaired shunts;,-pulmonary arterial hypertension associated with drugs and toxins;,in patients with who functional class ii, iii or iv symptoms
gabapentin 400mg capsules
noumed life sciences ltd - gabapentin - oral capsule - 400mg